Clinical Trial Update: Subcutaneous Administration of Lisofylline to Healthy Normal Subjects and Subjects With Type 1 Diabetes [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial update describing subcutaneous lisofylline in healthy subjects and in individuals with Type 1 diabetes, which has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• Lisofylline (lisofylline)

Snippet

Sponsor: DiaKine Therapeutics, Inc. | Conditions: Healthy, Type 1 Diabetes | Phase 1, Phase 2 | Status: COMPLETED